# Prevention of Malaria in HIV-uninfected Pregnant Women and Infants

> **NCT02793622** · PHASE3 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 782 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Monthly Sulfadoxine-Pyrimethamine (SP) During Pregnancy
- **DRUG:** Monthly Dihydroartemisinin-Piperaquine (DP) During Pregnancy

## Key facts

- **NCT ID:** NCT02793622
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-12-04
- **Final completion:** 2018-12-04
- **Target enrollment:** 782 (ACTUAL)
- **Last updated:** 2021-04-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02793622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02793622, "Prevention of Malaria in HIV-uninfected Pregnant Women and Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02793622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*